Second-Generation Antipsychotic Utilization and Metabolic Parameter Monitoring in an Inpatient Pediatric Population: A Retrospective Analysis
Background Second-generation antipsychotics (SGAs) are prescribed for a variety of indications and are strongly associated with adverse metabolic effects. Studies of pediatric outpatients have revealed several deficiencies in monitoring practices for adverse effects associated with SGAs. Objective O...
Gespeichert in:
Veröffentlicht in: | Paediatric drugs 2017-04, Vol.19 (2), p.139-146 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
Second-generation antipsychotics (SGAs) are prescribed for a variety of indications and are strongly associated with adverse metabolic effects. Studies of pediatric outpatients have revealed several deficiencies in monitoring practices for adverse effects associated with SGAs.
Objective
Our objective was to characterize SGA prescribing and metabolic parameter monitoring (MPM) in an inpatient pediatric population.
Methods
Patients aged |
---|---|
ISSN: | 1174-5878 1179-2019 |
DOI: | 10.1007/s40272-016-0209-x |